James Allison
PhD
Professor and Chair, Department of Immunology; Nobel Laureate
👥Biography 个人简介
James Allison is a Nobel Prize-winning immunologist (2018) whose discovery that blocking CTLA-4 unleashes immune attack on cancer led directly to the development of ipilimumab, the first approved immune checkpoint inhibitor. His foundational basic science at UC Berkeley and subsequent translational work opened the entire field of cancer immunotherapy. His work set the paradigm for PD-1/PD-L1 blockade and the immunotherapy revolution that has transformed oncology.
🧪Research Fields 研究领域
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Drew M. Pardoll
Johns Hopkins University
Padmanee Sharma
MD Anderson Cancer Center
Naiyer A. Rizvi
Columbia University Irving Medical Center
关注 James Allison 的研究动态
Follow James Allison's research updates
留下邮箱，当我们发布与 James Allison（The University of Texas MD Anderson Cancer Center）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment